Protagonist Therapeutics stock price target raised to $74 at Clear Street
PositiveFinancial Markets

Protagonist Therapeutics has received a boost as Clear Street has raised its stock price target to $74. This adjustment reflects growing confidence in the company's potential and could attract more investors. Such positive news is significant as it highlights the company's progress and the market's optimistic outlook on its future.
— Curated by the World Pulse Now AI Editorial System